Low‐dose immune tolerance induction in children with severe hemophilia A with high‐titer inhibitors: Type of factor 8 mutation and outcomes

BACKGROUND: No studies evaluated the role of F8 mutations in outcomes for low‐dose immune tolerance induction (ITI) in people with severe hemophilia A (SHA) with high‐titer inhibitors. OBJECTIVES: To explore the association between F8 mutation types and low‐dose ITI outcomes in children with SHA wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jie, Li, Zekun, Li, Gang, Huang, Kun, Ai, Di, Liu, Guoqing, Yao, Wanru, Xie, Xingjuan, Gu, Hao, Zhen, Yingzi, Chen, Zhenping, Wu, Runhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606347/
https://www.ncbi.nlm.nih.gov/pubmed/36313984
http://dx.doi.org/10.1002/rth2.12824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606347/
https://www.ncbi.nlm.nih.gov/pubmed/36313984
http://dx.doi.org/10.1002/rth2.12824

Ejemplares similares